ACF Investors
Venture Capital
Active
London, United Kingdom
144
3M
101
11.08
18
0.30
15
- Stages of investment
- Areas of investment
Summary
Angel CoFund is the famous VC, which was founded in 2011. The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the Sheffield.
When the investment is from Angel CoFund the average startup value is 1-5 millions dollars. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. The important activity for fund was in 2013. The increased amount of exits for fund were in 2019. Comparing to the other companies, this Angel CoFund performs on 20 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund.
This organization was formed by George Whitehead. We also calculated 3 valuable employees in our database.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Angel CoFund, startups are often financed by MMC Ventures, Northstar Ventures, Newable Private Investing. The meaningful sponsors for the fund in investment in the same round are MMC Ventures, Business Growth Fund, Wren Capital. In the next rounds fund is usually obtained by MMC Ventures, Unilever Ventures, SyndicateRoom.
Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology, Creo Medical, Gousto. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Health Care. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
- Check size
- 249K — 1M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- GBP 30000000
- Fund raised date
- 2021-01-26
Analytics
- Total investments
- 144
- Lead investments
- 18
- Exits
- 15
- Rounds per year
- 11.08
- Follow on index
- 0.30
- Investments by industry
- Software (29)
- Biotechnology (26)
- Health Care (23)
- Manufacturing (18)
- Food and Beverage (14) Show 167 more
- Investments by region
-
- United Kingdom (140)
- Germany (1)
- United States (3)
- Peak activity year
- 2013
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 23M
- Group Appearance index
- 0.78
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.69
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Adapttech | 06 Apr 2022 | Biotechnology, Medical Device | Early Stage Venture | 3M | England, Birmingham, United Kingdom |
Spotta | 15 Dec 2023 | Hospitality, Housekeeping Service | Early Stage Venture | 4M | England, Cambridge, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.